EFFECT OF METYRAPONE ON THE EXCRETION OF OESTROGEN IN MAN

in Journal of Endocrinology
Authors:
A. E. ARGÜELLES
Search for other papers by A. E. ARGÜELLES in
Current site
Google Scholar
PubMed
Close
,
H. MARTÍ
Search for other papers by H. MARTÍ in
Current site
Google Scholar
PubMed
Close
,
C. SABORIDA
Search for other papers by C. SABORIDA in
Current site
Google Scholar
PubMed
Close
, and
U. L. POGGI
Search for other papers by U. L. POGGI in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Hydroxylation at the angular C-19 methyl group is thought to be a necessary step for the biosynthesis of oestrogens since it is the first stage of aromatization (Meyer, 1955; Ryan, 1959).

Griffiths (1963) found that the dose of metyrapone which produced an inhibition of 11β-hydroxylase activity in the adrenal of the golden hamster also produced a decrease in the activity of the 19-hydroxylase. This indicated the use of metyrapone as an inhibitor of oestrogen biosynthesis. Földes, Koref, Fehér & Steczek (1964) suggested that metyrapone affects the adrenal and the ovary; they reported a decrease in the excretion of oestrone, 17β-oestradiol and oestriol with a particularly marked decrease of the oestradiol fraction, both on the day of treatment and on the day after. The same authors refer to a simultaneous increase of androsterone and aetiocholanolone originating possibly from androst-4-ene-3,17-dione, the concentration of which may increase with the decreased formation of 19

 

  • Collapse
  • Expand